Profiles in Business - March 22, 2017
“The scientist in me wants to make a difference”
After ten years of diabetes research and development at Novo Nordisk, Dorte X. Gram took her findings and work further to start something on her own. As founder and CEO of PILA PHARMA she hopes to bring a new oral anti-diabetic agent to the market. What made you take the leap to go on your […]
Clinical Trials - March 6, 2017
Regulatory approval for PILA PHARMA’s clinical trial application
PILA PHARMA has received regulatory approval of its first clinical trial application thus permitting the company to move its clinical development candidate, XEN-D0501, into a safety trial in type 2 diabetic patients. “I am very excited about finally being at the point where we can progress a TRPV1 antagonist into diabetic patients!”, says Dorte X. […]